Copy
HYPERTHERMIA NEWS - DECEMBER 2020 | ONLINE VERSION
Dr. Sennewald Medizintechnik

HYPERTHERMIA NEWS

Dear <<Title>> <<Last name>>,

Thank you for finding the time to read this newsletter during this particularly demanding period. As you are aware, many of our expert congresses were held online this year and we were pleasantly surprised by the level of participation, lively exchange and positive response among those who took part in our hyperthermia lunch symposium during the virtual ESTRO meeting.

You can now listen to two of the presentations given at the symposium by following the link below – courtesy of the kind permission given by Professor Gabriele Multhoff and Professor Pirus Ghadjar.

Wishing you and your family a peaceful holiday season,

Dr. Sennewald Medizintechnik GmbH

ESTRO-SYMPOSIUM

G. Multhoff PhD
GABRIELE MULTHOFF PhD
TUM Technical University Munich, Germany

“Targeted NK cell based adoptive immunotherapy for the treatment of patients with NSCLC after radiochemotherapy”

Virtual ESTRO Lecture, held November 28, 2020

ESTRO-SYMPOSIUM

P. Ghadjar MD
PIRUS GHADJAR MD
Charité UMC Berlin, Germany

“Combined regional hyperthermia and salvage radiation therapy for prostate cancer patients with biochemical recurrence after prostatectomy - current status and future perspectives”

Virtual ESTRO Lecture, held November 28, 2020

ONLINE/HYBRID EVENTS

Planned forthcoming events, subject to change 
IV Russian Scientific and Educational Congress with International Participation
47. Erlanger Weiterbildung

CONTACT US

Please contact us for specific information.
DIRK LUTTER
Sales Manager
dirk.lutter@sennewald.de
MONICA SENNEWALD
Marketing Director
monica.sennewald@sennewald.de
Dr. Sennewald Medizintechnik GmbH
Schatzbogen 86
München 81829
Germany

Add us to your address book
Fon: +49 (0)89 542143-20
Fax: +49 (0)89 542143-30
EFAX: +49 (0)89 95464138
Website: sennewald.de

Geschäftsführer: Dr. Dipl.-Ing. Gerhard W. Sennewald
Handelsregister: Amtsgericht München HRB 75654
USt-IdNr.: DE 129331634
WEEE-Reg.-Nr.: DE 22905506

Unsubscribe | Update data

You are receiving this email because we assume that you are interested in general information about hyperthermia in clinical oncology.

Copyright © 2020 Dr. Sennewald Medizintechnik GmbH, all rights reserved.